Clinical & Diagnostic
Abacus Medicine Partners with Mirum Pharmaceuticals to Commercialize LIVMARLI® in the Nordic Region
Abacus Medicine Pharma Services (‘Abacus’) announces the signing of a partnership agreement with Mirum Pharmaceuticals, Inc. (‘Mirum...
September 11, 2024 | News
A. Menarini Diagnostics and Nucleix Partner for Non-Invasive Bladder Cancer Test in Europe
Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe&...
September 10, 2024 | News
Lunit Integrates AI Biomarker into Roche's navify® Platform, Boosting Precision in Cancer Biomarker Testing
Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine an...
September 10, 2024 | News
Seegene Launches Advanced Novaplex™ Assay to Combat High-Mortality Mpox Clade I
Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Cla...
September 10, 2024 | News
Merck Launches Global Phase III Trial of Oral Cladribine for Generalized Myasthenia Gravis Treatment
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG) Cl...
September 06, 2024 | News
GC Biopharma and Hanmi Pharmaceutical Receive FDA Clearance for Phase 1/2 Trial of First Once-Monthly Subcutaneous Treatment for Fabry Disease
Co-development of innovative new drug for the treatment of Fabry disease as "the world's first once-monthly subcutaneous treatment" Improves efficacy co...
September 04, 2024 | News
Albatroz Therapeutics Joins Johnson & Johnson Innovation – JLABS Singapore to Accelerate Cancer Therapy Development
Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today announced its membership of Johnson &...
September 04, 2024 | News
Sanyou Biopharmaceuticals Introduces Comprehensive Monkeypox Product Line Featuring Antigens, Monoclonal Antibodies, and Overexpression Cell Lines
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced the launch of a comprehensive product line targeting monkeypox, which includes antigens, monoclona...
September 02, 2024 | News
Guardant Health Japan Secures MHLW Approval for Guardant360® CDx as First Blood-Based Companion Diagnostic for EGFR Exon 20 NSCLC Mutations
Guardant Health Japan , a leading precision oncology company, announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan&nbs...
August 30, 2024 | News
South Korea's Seegene Develops Advanced Multiplex PCR Assays for Mpox and Other Viruses
Develops NovaplexTM MPXV/OPXV Assay and NovaplexTM HSV-1&2/VZV/MPXV Assay - Designed to detect four viruses at once using multip...
August 27, 2024 | News
Mabwell Receives NMPA Approval to Initiate Phase III Study of 9MW2821 in Recurrent or Metastatic Cervical Cancer
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (C...
August 26, 2024 | News
Yipurun's Corina System Receives Approval in China for Treating Moderate-to-Severe Intrauterine Adhesions
Corina Intrauterine Drug-Eluting System ("Corina"), developed by Yipurun (Shanghai) Biotechnology Co., Ltd. ("YPR"), has received approval i...
August 26, 2024 | News
Finnish Biotech NADMED Secures €3.5M to Transform Vitamin B3 Testing with Groundbreaking NAD Measurement Technology
Finnish biotech company NADMED has developed the first test to measure all four bodily forms of vitamin B3, called NADs, and glutathiones directly from fre...
August 23, 2024 | News
Tackling Dengue: Insights from Leading Experts Amid Surge in Southeast Asia
In an exclusive interview with BioPharma APAC, Professor Ooi Eng Eong, a leading expert in Emerging Infectious Diseases at Duke-NUS Medical School,...
August 22, 2024 | Interview
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
